593 related articles for article (PubMed ID: 18467909)
1. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.
Sharma P; Sharma BC; Puri V; Sarin SK
Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):506-11. PubMed ID: 18467909
[TBL] [Abstract][Full Text] [Related]
2. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC; Sarin SK
Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
[TBL] [Abstract][Full Text] [Related]
3. Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC; Sarin SK
Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):27-32. PubMed ID: 20133225
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
Mittal VV; Sharma BC; Sharma P; Sarin SK
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
[TBL] [Abstract][Full Text] [Related]
5. Minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.
Sharma P; Sharma BC; Puri V; Sarin SK
Am J Gastroenterol; 2008 Jun; 103(6):1406-12. PubMed ID: 18510608
[TBL] [Abstract][Full Text] [Related]
6. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
Agrawal A; Sharma BC; Sharma P; Sarin SK
Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
[TBL] [Abstract][Full Text] [Related]
7. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy.
Sharma P; Sharma BC; Puri V; Sarin SK
J Hepatol; 2007 Jul; 47(1):67-73. PubMed ID: 17459511
[TBL] [Abstract][Full Text] [Related]
8. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
Sharma P; Sharma BC; Agrawal A; Sarin SK
J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
[TBL] [Abstract][Full Text] [Related]
9. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis.
Liu Q; Duan ZP; Ha DK; Bengmark S; Kurtovic J; Riordan SM
Hepatology; 2004 May; 39(5):1441-9. PubMed ID: 15122774
[TBL] [Abstract][Full Text] [Related]
10. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.
Sharma BC; Sharma P; Agrawal A; Sarin SK
Gastroenterology; 2009 Sep; 137(3):885-91, 891.e1. PubMed ID: 19501587
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychological impairment in severe acute viral hepatitis is due to minimal hepatic encephalopathy.
Sharma P; Sharma BC; Tyagi P; Kumar M; Sarin SK
Liver Int; 2009 Feb; 29(2):260-4. PubMed ID: 18710429
[TBL] [Abstract][Full Text] [Related]
12. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy.
Ziada DH; Soliman HH; El Yamany SA; Hamisa MF; Hasan AM
Arab J Gastroenterol; 2013 Sep; 14(3):116-22. PubMed ID: 24206740
[TBL] [Abstract][Full Text] [Related]
13. Predictors of minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC
Saudi J Gastroenterol; 2010; 16(3):181-7. PubMed ID: 20616413
[TBL] [Abstract][Full Text] [Related]
14. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy.
Prasad S; Dhiman RK; Duseja A; Chawla YK; Sharma A; Agarwal R
Hepatology; 2007 Mar; 45(3):549-59. PubMed ID: 17326150
[TBL] [Abstract][Full Text] [Related]
15. Natural history of minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.
Sharma P; Sharma BC; Puri V; Sarin SK
Am J Gastroenterol; 2009 Apr; 104(4):885-90. PubMed ID: 19293781
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of abnormal psychometric tests and critical flicker frequency after clinical recovery of overt hepatic encephalopathy.
Sharma P; Sharma BC; Sarin SK
Neurol India; 2010; 58(2):220-4. PubMed ID: 20508339
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis.
Luo M; Li L; Lu CZ; Cao WK
Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1250-7. PubMed ID: 21971378
[TBL] [Abstract][Full Text] [Related]
18. Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
Tromm A; Griga T; Greving I; Hilden H; Hüppe D; Schwegler U; Micklefield GH; May B
Hepatogastroenterology; 2000; 47(32):473-7. PubMed ID: 10791216
[TBL] [Abstract][Full Text] [Related]
19. [Effects of lactulose treatment on the course of subclinical hepatic encephalopathy].
Zeng Z; Li YY
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1126-9. PubMed ID: 12921628
[TBL] [Abstract][Full Text] [Related]
20. A randomized double blind placebo controlled trial of probiotics in minimal hepatic encephalopathy.
Saji S; Kumar S; Thomas V
Trop Gastroenterol; 2011; 32(2):128-32. PubMed ID: 21922877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
